Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$31.3M Sell
857,911
-5,635
-0.7% -$204K 2.17% 8
2015
Q3
$28.4M Sell
863,546
-96,614
-10% -$3.25M 1.84% 14
2015
Q2
$35.6M Sell
960,160
-156,739
-14% -$5.7M 1.9% 11
2015
Q1
$39.1M Buy
1,116,899
+1,377
+0.1% +$48.6K 1.8% 14
2014
Q4
$42.5M Sell
1,115,522
-14,091
-1% -$515K 1.96% 12
2014
Q3
$40.1M Buy
1,129,613
+44,528
+4% +$1.65M 1.7% 17
2014
Q2
$42.4M Buy
1,085,085
+41,689
+4% +$1.56M 1.63% 22
2014
Q1
$38M Buy
1,043,396
+148,854
+17% +$5.43M 1.47% 34
2013
Q4
$31M Buy
894,542
+10,491
+1% +$337K 1.35% 37
2013
Q3
$24.7M Buy
884,051
+68,136
+8% +$1.82M 1.16% 40
2013
Q2
$22M Buy
+815,915
New +$22.5M 1.12% 44

Other funds holding XYL

GW Capital's XYL Position: Q4 2015 in Review

GW Capital reduced its Xylem (XYL) stake by 0.65% in Q4 2015, selling an estimated $204K and leaving 857,911 shares worth $31.3M. The position accounts for 2.17% of the portfolio, ranked #8.

GW Capital first reported a position in XYL in Q2 2013 and has held it in 11 quarters since. The position peaked at $42.5M in Q4 2014. 443 funds tracked by Wall St. Rank hold XYL as of Q4 2015.

  • GW Capital held 857,911 shares of Xylem worth $31.3M as of Q4 2015.
  • GW Capital sold 5,635 Xylem shares in Q4 2015, an estimated $204K.
  • Xylem made up 2.17% of GW Capital's portfolio in Q4 2015, its #8 holding.
  • GW Capital first reported a position in Xylem in Q2 2013 and has held it in 11 quarters since.
  • GW Capital's Xylem position peaked at $42.5M in Q4 2014.
  • 443 funds tracked by Wall St. Rank held Xylem as of Q4 2015.

Based on GW Capital's 13F filing for Q4 2015, filed 19 Feb 2016.